Strategy Inc (NASDAQ:MSTR) reported Monday that during the week of December 15 to December 21, it did not sell any shares under its at-the-market (ATM) offering program for its listed securities. The ...
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...
Clinical strategy - The FLAMINGO-01 clinical strategy continues to evolve with various options to further reduce risk and increase the chances of marketing approval supported by the current financing ...
Hosted on MSN
Strategy raises $747.8M in its latest MSTR ATM sale
Strategy achieved another significant weekly raise, but bought no new BTC. Instead, the company pushed up its cash reserves, securing the upcoming dividend payments. Strategy achieved another weekly ...
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...
The Company recently attended a Noble Capital conference on December 3, 2025, where further details of the Company’s FLAMINGO-01 clinical strategy, financing strategy, and partnering strategy were ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Thomas J Catalano is a CFP and Registered ...
Michelle Lambright Black, Founder of CreditWriter.com and HerCreditMatters.com, is a leading credit expert and personal finance writer with nearly two decades of experience in the credit industry. She ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback